TITAN PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Titan Pharmaceuticals, Inc. - TTNP

MorningStar
2025.08.06 01:30
portai
I'm PortAI, I can summarize articles.

Kahn Swick & Foti, LLC, led by former Louisiana Attorney General Charles C. Foti, Jr., is investigating the proposed merger between Titan Pharmaceuticals, Inc. (TTNP) and KE Sdn. Bhd. Shareholders of Titan are expected to own about 13.3% of the merged entity. The firm aims to assess the fairness and adequacy of the merger process for Titan's shareholders. Interested parties can contact KSF for more information regarding their legal rights related to the transaction.

Source: MorningStar The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.